Trials / Completed
CompletedNCT07236333
The Role of CALLY and HAALP in Ulcerative Colitis
The Role of CALLY and HAALP Scores in the Evaluation of Ulcerative Colitis Attack
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Ataturk University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to demonstrate the type and amount of retention in the colon during ulcerative colitis activation, as well as the relationship between C-reactive protein (CRP), albumin and the calculated CALLY index. The investigators also aim to establish whether this ratio can be used to indicate activation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | CALLY | The CALLY index, integrating C-reactive protein (CRP), albumin, and lymphocyte count, has been identified as a promising prognostic biomarker. |
| DIAGNOSTIC_TEST | HALP | The HALP score is calculated as HALP Score = \[hemoglobin (g/L) × albumin (g/L) × lymphocytes (/L)\]/platelets (/L). It is a definitive biomarker. |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2024-12-31
- Completion
- 2025-03-31
- First posted
- 2025-11-19
- Last updated
- 2025-11-19
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07236333. Inclusion in this directory is not an endorsement.